Changes in gene expression in atherosclerotic plaques analyzed using DNA array

Atherosclerosis

Volumn 165, Issue 1, 2002, Pages 23-32

  Hiltunen, Mikko O ^a   Tuomistol, T T ^a   Niemi, Mari ^a   Brásen, Jan H ^a,b   Rissanen, Tuomas T ^a   Tórónen, Petri ^a   Vajanto, Ismo ^a   Ylá Herttuala, Seppo ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b HUMBOLDT UNIVERSITY   (Germany)

Author keywords

Atherosclerosis; Cell communication; Gene expression profiling; Sequence; Signal transduction

Indexed keywords

APOLIPOPROTEIN E; CHLORDANE; COMPLEMENTARY DNA; DNA FRAGMENT; ISOENZYME; JANUS KINASE; PHOSPHOLIPASE D; TISSUE INHIBITOR OF METALLOPROTEINASE; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ADULT; AGED; ANGIOGENESIS; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL PROLIFERATION; CHROMOSOME 19; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; ENZYME INDUCTION; FEMALE; GENE MAPPING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE ACTIVATION; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; VALIDATION PROCESS;

ADULT; AGED; ARTERIOSCLEROSIS; BASE SEQUENCE; CULTURE TECHNIQUES; DNA, COMPLEMENTARY; DOWN-REGULATION; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SEVERITY OF ILLNESS INDEX;

EID: 0036840612     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(02)00187-9     Document Type: Article

References (38)

1. Duggan D.J., Bittner M., Chen Y., Meltzer P., Trent J.M. Expression profiling using cDNA microarrays. Nat. Genet. 21:1999;10-14.
2. Hiltunen M.O., Niemi M., Yla-Herttuala S. Functional genomics and DNA array techniques in atherosclerosis research. Curr. Opin. Lipidol. 10:1999;515-519.
3. Debouck C., Goodfellow P.N. DNA microarrays in drug discovery and development. Nat. Genet. 21:1999;48-50.
4. Ross R. Mechanisms of disease - atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340:1999;115-126.
5. Adams L.D., Geary R.L., McManus B., Schwartz S.M. A comparison of aorta and vena cava medial message expression by cDNA array analysis identifies a set of 68 consistently differentially expressed genes, all in aortic media. Circ. Res. 87:2000;623-631.
6. McCaffrey T.A., Fu C., Du B., Eksinar S., Kent K.C., Bush H. Jr., et al. High-level expression of Egr-1 and Egr-1-inducible genes in mouse and human atherosclerosis. J. Clin. Invest. 105:2000;653-662.
7. Zohlnhófer D., Klein C.A., Richter T., Brandl R., Murr A., Nührenberg T., et al. Gene expression profiling of human stent-induced neointima by cDNA array analysis of microscopic specimens retrieved by helix cutter atherectomy. Circulation. 103:2001;1396-1402.
8. Wuttge D.M., Sirsjó A., Eriksson P., Stemme S. Gene expression in atherosclerotic lesion of ApoE deficient mice. Mol. Med. 7:2001;383-392.
9. Faber B.C.G., Cleutjens K.B.J.M., Niessen R.L.J., Aarts P.L.J.W., Boon W., Greenberg A.S., et al. Identification of genes potentially involved in rupture of human atherosclerotic plaques. Circ. Res. 89:2001;547-554.
10. Ylá-Herttuala S., Rosenfeld M.E., Parthasarathy S., et al. Colocalization of 15-lipoxygenase mRNA and protein with epitopes of oxidized low density lipoprotein in macrophage-rich areas of atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 87:1990;6959-6963.
11. Stary H.C., Chandler A.B., Dinsmore R.E., et al. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the committee on vascular lesions of the council on arteriosclerosis, American Heart Association. Circulation. 92:1995;1355-1374.
12. Claverie J.M. Computational methods for the identification of differential and coordinated gene expression. Hum. Mol. Genet. 8:1999;1821-1832.
13. Hiltunen T.P., Luoma J.S., Nikkari T., et al. Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, and scavenger receptor in rabbit atherosclerotic lesions: marked induction of scavenger receptor and VLDL receptor expression during lesion development. Circulation. 97:1998;1079-1086.
14. Gabbiani G., Kocher O., Bloom W.S., Vandekerckhove J., Weber K. Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. J. Clin. Invest. 73:1984;148-152.
15. Sukhova G.K., Shi G.P., Simon D.I., Chapman H.A., Libby P. Expression of the elastolytic cathepsins S and K in human atheroma and regulation of their production in smooth muscle cells. J. Clin. Invest. 102:1998;576-583.
16. Tyagi S.C., Meyer L., Kumar S., Schmaltz R.A., Reddy H.K., Voelker D.J. Induction of tissue inhibitor of metalloproteinase and its mitogenic response to endothelial cells in human atherosclerotic and restenotic lesions. Can. J. Cardiol. 12:1996;353-362.
17. Stenman S., von Smitten K., Vaheri A. Fibronectin and atherosclerosis. Acta Med. Scand. Suppl. 642:1980;165-170.
18. Hollander W., Colombo M.A., Kirkpatrick B., Paddock J. Soluble proteins in the human atherosclerotic plaque. With spectral reference to immunoglobulins, C3-complement component, alpha 1-antitrypsin and alpha 2-macroglobulin. Atherosclerosis. 34:1979;391-405.
19. Aviram M., Kent U.M., Hollenberg P.F. Microsomal cytochromes P450 catalyze the oxidation of low density lipoprotein. Atherosclerosis. 143:1999;253-260.
20. Ramprasad M.P., Terpstra V., Kondratenko N., Quehenberger O., Steinberg D. Cell surface expression of mouse macrosialin and human CD68 and their role as macrophage receptors for oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 93:1996;14 833-14 838.
21. Kiener P.A., Rankin B.M., Davis P.M., Yokum S.A., Warr G.A., Grove R.I. Immune complexes of LDL induce atherogenic responses in human monocytic cells. Arterioscler. Thromb. Vasc. Biol. 15:1995;990-999.
22. Salomon R.N., Underwood R., Doyle M.V., Wang A., Libby P. Increased apolipoprotein E and c-fms gene expression without elevated interleukin 1 or 6 mRNA levels indicates selective activation of macrophage functions in advanced human atheroma. Proc. Natl. Acad. Sci. USA. 89:1992;2814-2818.
23. Pillarisetti S., Paka L., Obunike J.C., Berglund L., Goldberg I.J. Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. J. Clin. Invest. 100:1997;867-874.
24. Bello A.T., Bora N.S., Lange L.G., Bora P.S. Cardioprotective effects of alcohol: mediation by human vascular alcohol dehydrogenase. Biochem. Biophys. Res. Commun. 203:1994;1858-1864.
25. Natarajan V., Scribner W.M., Hart C.M., Parthasarathy S. Oxidized low density lipoprotein-mediated activation of phospholipase D in smooth muscle cells: a possible role in cell proliferation and atherogenesis. J. Lipid Res. 36:1995;2005-2016.
26. Watson K.E., Parhami F., Shin V., Demer L.L. Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory. Arterioscler. Thromb. Vasc. Biol. 18:1998;1964-1971.
27. Campbell J.H., Popadynec L., Nestel P.J., Campbell G.R. Lipid accumulation in arterial smooth muscle cells. Influence of phenotype. Atherosclerosis. 47:1983;279-295.
28. Kagawa Y., Uchida E., Yokota H., Yamaguchi M., Taniyama H. Immunohistochemical localization of apolipoprotein B-100 (ApoB-100) and expression of glutathione peroxidase (GSH-PO) in canine atherosclerotic lesions. Vet. Pathol. 35:1998;227-229.
29. Balaram S.K., Agrawal D.K., Edwards J.D. Insulin like growth factor-1 activates nuclear factor-kappa B and increases transcription of the intercellular adhesion molecule-1 gene in endothelial cells. Cardiovasc Surg. 7:1999;91-97.
30. Batetta B., Dessi S., Putzolu M., et al. MDR1 gene expression in normal and atherosclerotic human arteries(1). J. Vasc. Res. 36:1999;261-271.
31. Hwang D.M., Dempsey A.A., Wang R.X., et al. A genome-based resource for molecular cardiovascular medicine: toward a compendium of cardiovascular genes. Circulation. 96:1997;4146-4203.
32. Tuomisto T., Ylá-Herttuala S. Genes involved in atherosclerosis and plaque formation. Van Eyk J., Proteomic and genomic analysis of cardiovascular disease. 2002;Wiley-VCH GmbH, Weinhein.
33. Choudhury G.G., Ghosh-Choudhury N., Abboud H.E. Association and direct activation of signal transducer and activator of transcription1alpha by platelet-derived growth factor receptor. J. Clin. Invest. 101:1998;2751-2760.
34. Brekken R.A., Overholser J.P., Stastny V.A., Waltenberger J., Minna J.D., Thorpe P.E. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice. Cancer Res. 60:2000;5117-5124.
35. Klouche M., May A.E., Hemmes M., et al. Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers. Arterioscler. Thromb. Vasc. Biol. 19:1999;784-793.
36. Tórónen P., Kolehmainen M., Wong G., Castren E. Analysis of gene expression data using self-organizing maps. FEBS Lett. 451:1999;142-146.
37. Iyer V.R., Eisen M.B., Ross D.T., et al. The transcriptional program in the response of human fibroblasts to serum. Science. 283:1999;83-87.
38. Laukkanen J., Ylá-Herttuala S. Genes involved in atherosclerosis. Exp. Nephrol. 10:2002;150-163.